Friday, November 22, 2024
11/22/2024
The HMC MAT-PDOA will expand access to integrated medication assisted treatment (MAT) for individuals with opioid use disorder (OUD). Building on our successful experience with a proven model of providing MAT in an urban safety net medical setting, we will increase capacity to treat more patients and enhance services for homeless and high-cost inpatient hospital and Emergency Department (ED) patients with opioid use disorder. HMC-MAT-PDOA is a collaborative effort between Harborview Medical Center and Washington State to address the rising rates of opioid-related problems in Washington State, including overdose deaths and addiction treatment admissions. The populations to be served are adults with OUD in King County, Washington who are treated in a primary care clinic serving a predominantly homeless population, and patients who are initiated in MAT during an inpatient hospital or Emergency Department admission. Strategies and interventions include two Evidence-Based Practices (EBPs): 1) MAT with buprenorphine/naloxone, extended-release naltrexone, or injectable buprenorphine, and 2) The Massachusetts Nurse Care Manager Model for providing MAT in medical settings. In addition, to address the specific needs of the target population, peer navigation services and inpatient Addiction Medicine physician consultations will be used to assess hospitalized patients for MAT, choose the appropriate medication, and collaborate with inpatient teams to initiate MAT and connect patients with transitional and primary care. Project goals are to: 1) increase MAT capacity using a proven model for providing integrated services in primary care settings; 2) develop enhanced services for hospitalized Trauma Center and Emergency Department patients with high morbidity and medical costs related to OUD; and 3) advance DATA 2000 training for eligible medical providers, including internal medicine residents serving marginalized patients in the primary care setting. Objectives include, but are not limited to: 1) serve 396 unduplicated patients over a three-year period (108 in year 1, and 144 in year 2 and 144 in year 3), 2) assure access to comprehensive services in a culturally competent, patient-centered care manner, 3) reduce adverse OUD-related outcomes and substance use from baseline to 6-month follow-up, 4) maximize retention in MAT, 5) increase the number of high-cost hospitalized patients who are engaged in MAT through physician consultations, 6) increase the use of peer navigation support for high need patients, 7) reduce the likelihood of medication diversion, 8) seek sustainable program financing, and 9) train clinical staff in the use of EBPs, including DATA waiver training. This project will be done in collaboration with the Washington State Research and Data Analysis, and Health Care Authority that will provide technical support, ongoing evaluation, policy support, and pursuit of model sustainability.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
